Login:
 
Rees J. Can one drug be discontinued in combination therapy for LUTS? Practitioner 2014 ; 258 (1769): 8

Can one drug be discontinued in combination therapy for LUTS?

20 Mar 2014Pais-up subscribers

Patients with BPH being treated with combination therapy for LUTS are more likely to be able to stop the alpha blocker treatment than the 5-alpha reductase inhibitor (5-ARI), a study from Taiwan suggests.[With external links to the current evidence base]

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .